Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Initial treatment of idiopathic nephrotic syndrome in children with mycophenolate mofetil vs. prednisone
2014-001991-76Phase 3Terminated
- Sponsor
- Heidelberg University
- Start
- Oct 2014
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Idiopathic nephrotic syndrome (INS) and nephrosis comparing Mycophenolate mofetil initial therapy with High-dose prednisone standard regimen (2 arms). Primary endpoint: Occurrence of treated relapse within 24 months after end of initial treatment. Started Oct 2014; status: terminated.
02
Drugs
mycophenolate mofetilprednisone
03
Conditions
Idiopathic nephrotic syndrome (INS)nephrosis
Beyond the preview
Go deeper on 2014-001991-76.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001991-76.